Steadview Capital Management’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-623,660
Closed -$20.3M 13
2025
Q4
$20.3M Sell
623,660
-78,185
-11% -$3.35M 3.81% 6
2025
Q3
$39.8M Buy
701,845
+311,845
+80% +$16M 5.71% 6
2025
Q2
$19.4M Buy
+390,000
New +$17.6M 2.81% 9

Other funds holding HIMS

Steadview Capital Management's HIMS Position: Q1 2026 in Review

Steadview Capital Management sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 623,660 shares — an estimated $20.3M sold.

Steadview Capital Management first reported a position in HIMS in Q2 2025 and held it in 3 quarters. The position peaked at $39.8M in Q3 2025. 436 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Steadview Capital Management reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Steadview Capital Management sold 623,660 Hims & Hers Health shares in Q1 2026, an estimated $20.3M.
  • Steadview Capital Management first reported a position in Hims & Hers Health in Q2 2025 and held it in 3 quarters.
  • Steadview Capital Management's Hims & Hers Health position peaked at $39.8M in Q3 2025.
  • 436 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Steadview Capital Management's 13F filing for Q1 2026, filed 1 May 2026.